This session will showcase cutting-edge methods and practical applications of structure-based drug design (SBDD) and computational tools in modern drug discovery pipelines. Experts will discuss how advanced computational techniques ? including molecular modeling, molecular dynamics, virtual screening, and AI-driven design ? are accelerating the identification and optimization of drug candidates. The session will also cover recent successes, challenges in predicting binding affinities, and integration of computational workflows with experimental validation